Nalaganje...
Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
INTRODUCTION: We present the results of real-life tests conducted in adults affected by psoriatic arthritis (PsA) with mild cutaneous involvement to evaluate the efficacy of certolizumab pegol (CZP), an anti-tumor necrosis factor-alpha agent approved in Europe for the treatment of rheumatoid arthrit...
Shranjeno v:
| izdano v: | Dermatol Ther (Heidelb) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Healthcare
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5698207/ https://ncbi.nlm.nih.gov/pubmed/29139035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-017-0208-z |
| Oznake: |
Označite
Brez oznak, prvi označite!
|